What OpenAI Really Wants
By Steven Levy,
Wired
| 09. 05. 2023
The air crackles with an almost Beatlemaniac energy as the star and his entourage tumble into a waiting Mercedes van. They’ve just ducked out of one event and are headed to another, then another, where a frenzied mob awaits. As they careen through the streets of London—the short hop from Holborn to Bloomsbury—it’s as if they’re surfing one of civilization’s before-and-after moments. The history-making force personified inside this car has captured the attention of the world. Everyone wants a piece of it, from the students who’ve waited in line to the prime minister.
Inside the luxury van, wolfing down a salad, is the neatly coiffed 38-year-old entrepreneur Sam Altman, cofounder of OpenAI; a PR person; a security specialist; and me. Altman is unhappily sporting a blue suit with a tieless pink dress shirt as he whirlwinds through London as part of a monthlong global jaunt through 25 cities on six continents. As he gobbles his greens—no time for a sit-down lunch today—he reflects on his meeting the previous night with French president Emmanuel Macron. Pretty good guy! And very...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...